Trans-(1R,3R)-3-[[3-[4-(oxan-4-yloxy)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]cyclopentane-1-carboxamide
C21H25N7O3 — CID 90391124
Data last refreshed: (MolForge compound catalog, from PubChem)
About Trans-(1R,3R)-3-[[3-[4-(oxan-4-yloxy)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]cyclopentane-1-carboxamide
Trans-(1R,3R)-3-[[3-[4-(oxan-4-yloxy)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]cyclopentane-1-carboxamide (PubChem CID 90391124) has the molecular formula C21H25N7O3 and a molecular weight of 423.48 g/mol. Its IUPAC name is trans-(1R,3R)-3-[[3-[4-(oxan-4-yloxy)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]cyclopentane-1-carboxamide.
Molecular Properties
| Compound Name | Trans-(1R,3R)-3-[[3-[4-(oxan-4-yloxy)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]cyclopentane-1-carboxamide |
|---|---|
| PubChem CID | 90391124 |
| Molecular Formula | C21H25N7O3 |
| Molecular Weight | 423.48 g/mol |
| Exact Mass | 423.20 |
| IUPAC Name | trans-(1R,3R)-3-[[3-[4-(oxan-4-yloxy)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]cyclopentane-1-carboxamide |
| SMILES | NC(=O)[C@@H]1CC[C@@H](Nc2ncc3nnn(-c4ccc(OC5CCOCC5)cc4)c3n2)C1 |
| InChI | InChI=1S/C21H25N7O3/c22-19(29)13-1-2-14(11-13)24-21-23-12-18-20(25-21)28(27-26-18)15-3-5-16(6-4-15)31-17-7-9-30-10-8-17/h3-6,12-14,17H,1-2,7-11H2,(H2,22,29)(H,23,24,25)/t13-,14-/m1/s1 |
| InChIKey | WRYLPEGCXQSVOS-ZIAGYGMSSA-N |
| XLogP | 1.83 |
| TPSA | 130.07 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 423.48 |
| LogP ≤ 5 | 1.83 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90391124 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.